e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
326.10
-4.01 (-1.21%)
Official Closing Price
Updated: 4:15 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,121,338
Open
328.81
Bid (Size)
323.60 (80)
Ask (Size)
326.97 (320)
Prev. Close
330.11
Today's Range
323.89 - 332.07
52wk Range
260.55 - 346.38
Shares Outstanding
538,500,000
Dividend Yield
2.92%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)
January 09, 2026
As of January 9, 2026, Eli Lilly and Company (NYSE:LLY) has transitioned from a stalwart of the American pharmaceutical industry to a global financial phenomenon. Having recently crossed the historic...
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
Performance
YTD
-0.5%
-0.5%
1 Month
+3.4%
+3.4%
3 Month
+12.4%
+12.4%
6 Month
+10.4%
+10.4%
1 Year
+24.4%
+24.4%
More News
Read More
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
Why Is ZBIO Stock Falling Pre-Market Today?
↗
January 06, 2026
Via
Stocktwits
Can These Dividend Stocks Beat the Market Again in 2026?
↗
January 08, 2026
Via
The Motley Fool
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The Trillion-Dollar Pivot: Eli Lilly Unleashes Volume-Led Strategy to Cement Obesity Market Dominance in 2026
January 06, 2026
Via
MarketMinute
Topics
Economy
1 S&P 500 Stock with Exciting Potential and 2 We Question
January 04, 2026
Via
StockStory
Topics
Stocks
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
January 02, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
World Trade
The Rise of the 'Dividogs': Small-Cap Yield Kings Poised to Lead the 2026 Market Rotation
January 02, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
January 02, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question
December 30, 2025
Via
StockStory
Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings?
December 30, 2025
Via
StockStory
Topics
Stocks
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
December 29, 2025
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
3 Profitable Stocks with Competitive Advantages
December 28, 2025
Via
StockStory
Barking Back: Why the 'Dogs of the Dow' 4-Stock Play is the Contrarian Bet for 2026
December 25, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The Oral Revolution: Novo Nordisk’s High-Stakes Bet on the Wegovy Pill
December 25, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
World Trade
The Trillion-Dollar Pharma: A Deep Dive into Eli Lilly’s (LLY) Dominance in the Weight-Loss Era
December 25, 2025
Via
PredictStreet
Topics
Economy
Government
Intellectual Property
The Atomic Architect: How University of Washington’s Generative AI Just Rewrote the Rules of Medicine
December 24, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era
December 24, 2025
Via
PredictStreet
Topics
Economy
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
December 23, 2025
Via
Stocktwits
Topics
Government
SCHD vs. NOBL: Different Paths to Dividend Stability
↗
December 22, 2025
Via
The Motley Fool
Topics
ETFs
Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers
December 21, 2025
Via
StockStory
Topics
Artificial Intelligence
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants
↗
December 19, 2025
Via
Stocktwits
Topics
Government
World Trade
The Great Biotech Re-Shoring: Seres Therapeutics and the New Commodity-Driven Era
December 19, 2025
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
Frequently Asked Questions
Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 326.10
When was Amgen last traded?
The last trade of Amgen was at 01/09/26 04:15 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 175.60B
How many shares of Amgen are outstanding?
Amgen has 176B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert